CompletedPhase 2NCT03496571
A Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis
Studying Eosinophilic gastroenteritis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Allakos Inc.
- Principal Investigator
- Henrik Rasmussen, MD, PhD, M.DAllakos Inc.
- Intervention
- AK002(drug)
- Enrollment
- 65 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2018 – 2019
Study locations (21)
- Phoenician Centers for Research and Innovation, Phoenix, Arizona, United States
- Mayo Clinic, Scottsdale, Arizona, United States
- Ventura Clinical Trials, Ventura, California, United States
- UC Denver, Aurora, Colorado, United States
- Riverside Clinical Research, Edgewater, Florida, United States
- Advanced Research Institute, New Port Richey, Florida, United States
- Northwestern, Chicago, Illinois, United States
- Indiana University Health, Indianapolis, Indiana, United States
- University of Iowa, Iowa City, Iowa, United States
- National Institutes of Health, Bethesda, Maryland, United States
- Tufts Medical Center, Boston, Massachusetts, United States
- Mayo Clinic, Rochester, Minnesota, United States
- Icahn School of Medicine at Mount Sinai, New York, New York, United States
- University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States
- Cincinnati Children's Hospital, Cincinnati, Ohio, United States
- +6 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03496571 on ClinicalTrials.govOther trials for Eosinophilic gastroenteritis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07506746PRospective Registry of Esophageal MotilityIRCCS San Raffaele
- ACTIVE NOT RECRUITINGPHASE2NCT05831176A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May HaveRegeneron Pharmaceuticals